[SCHEDULE 13G/A] TopBuild Corp. SEC Filing

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

SCHEDULE 13G/A

Rhea-AI Filing Summary

FMR LLC (parent holding company for Fidelity) and its controlling person Abigail P. Johnson filed Amendment No. 9 to Schedule 13G on 08 Aug 2025 for Taysha Gene Therapies Inc. (TSHA).

Beneficial ownership: 15,627,821.87 common shares, representing 6.2 % of the outstanding class as of 30 Jun 2025.
Control rights: Sole voting power over 15,622,332 shares and sole dispositive power over the full 15.628 million; no shared voting or dispositive authority is reported.
Filing status: Report made under Rule 13d-1(b) as a parent holding company/HC; ownership is held in the ordinary course of business without intent to influence control.
The amendment keeps FMR above the 5 % reporting threshold, signalling continued material institutional exposure to TSHA.

Insights

TL;DR: Fidelity still owns 6.2 % of TSHA, signalling sustained institutional support; impact neutral-to-positive.

FMR鈥檚 15.6 M-share stake confirms that one of the world鈥檚 largest asset managers retains a meaningful position in TSHA. While the filing doesn鈥檛 disclose whether the position was raised or trimmed, remaining above the 5 % threshold often underpins liquidity and can reduce free-float volatility. Sole voting and dispositive power allow Fidelity to act quickly on corporate actions, but its 13G (rather than 13D) status indicates passive intent. For investors, the disclosure is supportive but not transformative; fundamentals and clinical progress still dominate the equity story.

TL;DR: Passive 6.2 % holding gives Fidelity influence without activism; governance risk unchanged.

Because FMR files on Schedule 13G, it affirms no immediate plan to influence TSHA鈥檚 strategy or board composition. Nonetheless, Fidelity鈥檚 ability to cast 6 % of votes can be pivotal in close proxy matters. The unchanged passive classification limits near-term governance friction, but management must still consider large-holder preferences on capital allocation and executive comp. Overall governance impact is limited and largely status quo.

08/06/2025 - 12:14 PM

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

TOPBUILD CORP

(Name of Issuer)

COMMON STOCK

(Title of Class of Securities)

89055F103

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No.

89055F103

Names of Reporting Persons

FMR LLC

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

Sec Use Only

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,076,732.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,081,232.44
8	Shared Dispositive Power 0.00

Aggregate Amount Beneficially Owned by Each Reporting Person

2,081,232.44

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Percent of class represented by amount in row (9)

7.3 %

Type of Reporting Person (See Instructions)

SCHEDULE 13G

CUSIP No.

89055F103

Names of Reporting Persons

Abigail P. Johnson

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

Sec Use Only

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,081,232.44
8	Shared Dispositive Power 0.00

Aggregate Amount Beneficially Owned by Each Reporting Person

2,081,232.44

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Percent of class represented by amount in row (9)

7.3 %

Type of Reporting Person (See Instructions)

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

FMR LLC

Signature:	Richard Bourgelas
Name/Title:	Duly authorized under Power of Attorney effective as of May 23, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
Date:	08/05/2025

Abigail P. Johnson

Signature:	Richard Bourgelas
Name/Title:	Duly authorized under Power of Attorney effective as of May 23, 2023, by and on behalf of Abigail P. Johnson*
Date:	08/05/2025

Comments accompanying signature: *This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on August 8, 2023, accession number: 0000315066-23-002397.

Exhibit Information

Please see Exhibit 99 for 13d-1(k) (1) agreement.

Source:

AG真人官方